Radient Announces Partnership with All Good for Cannabis Pre-Roll Production and Provides Shareholder Update


Ryan Allway

January 5th, 2022

News


Edmonton, Alberta–(Newsfile Corp. – January 5, 2022) – Radient Technologies Inc. (TSXV: RTI) (“Radient” or the “Company”), a commercial manufacturer of diverse, novel, and high-quality cannabis extracts and packaged products, announces a partnership agreement with All Good Collective Corp. (“All Good”) to produce unique cannabis pre-roll products and provides a shareholder update.

 

Cannabis Pre-Roll Production
Radient has entered an agreement with All Good to design and supply a modular-designed assembly and packaging facility to produce cannabis pre-roll products. The facility will operate in Radient’s existing Edmonton II licenced plant, and first phase installation has already commenced. All Good has designed the facility to scale production capacity to at least 10 million cannabis pre-roll units (1 million packages) per month once full-scale modular build out is reached, and All Good has already secured the supply of the equipment required to reach full-scale build out.

 

Radient now plans to produce and sell cannabis pre-roll products to licenced retailers in Canada. The pre-roll design parameters include a cigarette-style cylinder format and craft grown, terpene rich, high THC, non-irradiated cannabis. Pre-roll units will be packaged in a high quality 10-unit humidity protected box and will be marketed to discerning cannabis users.

 

Staffing for the pre-roll production facility is expected to be in place by the end of January 2022, and initial pre-roll production and sales to licenced retailers is expected to commence thereafter.

 

Shareholder Update
Harry Kaura, CEO of Radient, provides the following update to shareholders:

Our team has worked diligently this year to restructure Radient and bring in new partnerships and develop new business lines to plot our new path forward. In February 2021, I agreed to serve as Radient’s CEO to lead these restructuring initiatives, which was also a demonstration of my continued confidence in Radient’s ability to be a meaningful player in the cannabis industry. As we begin the new year, I would like to highlight our key achievements of 2021 which we believe contribute instrumentally to Radient’s success:

  1. Received from Health Canada a dried cannabis sales licence and sale for medical purposes licence, allowing Radient to now offer a comprehensive suite of cannabis products,
  2. Licence and extraction agreement with HighGrade Supply for high grade cannabis 2.0 products expected to be available in retail stores in January 2022,
  3. Licence agreement with Atomic Eh! To build a cannabis brand and products, now launched in six provinces with several new SKUs coming to market soon in the pre-roll and dried flower categories,
  4. Licence agreement to co-develop and sell premium cannabis products under the Tunaaaaroom Xtracts brand, which are now sold through provincially licenced retailers in seven Canadian provinces and territories,
  5. Definitive agreement to acquire Tunaaaaroom Xtracts Inc., which is expected to close soon,
  6. Raised $2.7 million in aggregate through equity financings in March and December 2021, and
  7. Reached agreement with All Good to produce pre-roll products, as announced today.

Radient’s board of directors, management team, new partners, and I continue to be energized in our efforts toward Radient’s success and building shareholder value. We thank you for your ongoing support of our efforts to do so.

 

About Radient
Radient Technologies is a commercial manufacturer of diverse, novel, and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. RadientInc.com

 

Contact Information:
Harry Kaura, CEO & Director
ir@radientinc.com
Ph: 780 465 1318

 

Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the Company’s ability to install, staff, and scale the proposed pre-roll cannabis products production facility and to produce, package, market, and sell pre-roll cannabis products within the timeframes specified herein, the Company’s ability to make available high grade cannabis 2.0 products in retail stores and new SKUs in the pre-roll and dried flower categories within the timelines set out herein, the impact of the partnership agreement with All Good, the Company’s ability to complete the acquisition of Tunaaaaroom Xtracts Inc. and the expected timing of completion, and the Company’s business operations and future performance. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; risks associated with operation in the cannabis sector; and other risks inherent in the cannabis industry. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

 

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading